Penicillin for Post-Streptococcal Glomerulonephritis
No, Sumapen (penicillin V) is not prescribed to treat post-streptococcal glomerulonephritis (PSGN) itself, but it may be used to eradicate residual streptococcal infection if present at diagnosis.
Role of Antibiotics in PSGN
The management of PSGN is primarily supportive, as the disease is self-limiting and antibiotics do not alter the course of established glomerulonephritis 1, 2. However, penicillin has a limited role:
When Penicillin May Be Considered:
- Eradication of active infection: If there is evidence of ongoing streptococcal pharyngitis or skin infection at the time of PSGN diagnosis, antibiotics can eliminate the bacterial source 1
- Prevention of transmission: Treating active infection prevents spread to close contacts 1
- No therapeutic benefit for nephritis: Antibiotics do not prevent PSGN development once the immune-mediated process has begun, nor do they improve kidney outcomes 3
Evidence on Antibiotic Efficacy:
Research shows no advantages of various antimicrobials (including cefuroxime and ceftibuten) over penicillin V when given for pharyngitis, and critically, none prevent the development of APSGN once the immune process is triggered 3. The pathogenesis involves immune complex deposition and complement activation that occurs after the initial infection, making antibiotics ineffective against the glomerulonephritis itself 4, 2.
Actual Treatment of PSGN
The cornerstone of PSGN management is supportive care focused on managing complications:
Primary Interventions:
- Fluid restriction to manage hypervolemia 2
- Antihypertensive therapy: ACE inhibitors (captopril, enalapril) show superior blood pressure control and improved echocardiographic changes compared to other antihypertensives 3
- Diuretics for edema and volume overload 1, 2
- Nifedipine for acute hypertensive episodes 3
Severe Complications Requiring Escalation:
- Renal replacement therapy (dialysis) for severe acute kidney injury 1, 2
- Immunosuppressants only for crescentic PSGN with rapidly progressive glomerulonephritis, though evidence shows no clear advantage over supportive therapy alone 3
Common Pitfall:
Do not prescribe antibiotics expecting them to improve kidney function or reduce proteinuria in established PSGN—this is ineffective and not evidence-based 3, 1. The immune-mediated damage is already underway by the time clinical nephritis appears 4.
Prognosis Considerations
Most children achieve complete recovery with supportive management alone 1, 2. Poor prognostic indicators include crescent formation on biopsy, renal insufficiency at presentation, and persistent proteinuria or hypertension 2.